$CYTR CytRx Corporation Relaunches as LadRx Corporation

on September 23, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire
Read more

$CYTR European Patent Office Awards CytRx Key Patent

on September 7, 2022 News and Tags: , , , with 0 comments
Time:
9:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire
Read more

$CYTR CytRx Welcomes Cary J. Claiborne to the CytRx Board of Directors

on August 9, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire
Read more

$CYTR CytRx Announces Distribution of Series D Preferred Stock to Holders of Its Common Stock

on May 19, 2022 News and Tags: , , , with 0 comments
Time:
4:30 PM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire
Read more

$CYTR CytRx Highlights Strategic Purchase of Arimoclomol by KemPharm, Inc.

on May 17, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire
Read more

$CYTR CytRx to Participate in the H.C. Wainwright BioConnect Virtual Conference

on January 7, 2022 News and Tags: , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Announces the Appointment of Dr. Stephen Snowdy as Chief Executive Officer

on January 3, 2022 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Highlights ImmunityBio’s Use of Aldoxorubicin in Ongoing Clinical Studies for Various Forms of Cancer

on December 21, 2021 News and Tags: , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Comments on Quarterly Results and Recent Strategic Initiatives

on November 12, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more

$CYTR CytRx Highlights Orphazyme’s Published Results From Its Phase 2/3 Trial of Arimoclomol in Niemann-Pick Disease Type C

on August 24, 2021 News and Tags: , , , , , , , , , , , with 0 comments
Time:
8:00 AM
Symbol:
CYTR
Company:
CytRx Corp.
Source:
Business Wire News Releases
Read more